Financhill
Back

Xilio Therapeutics, Inc. Stock Predictions

Xilio Therapeutics, Inc. Stock Forecast

  • Is Xilio Therapeutics, Inc. Stock Undervalued?
    The current Xilio Therapeutics, Inc. [XLO] share price is $0.67. The Score for XLO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • XLO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Xilio Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Xilio Therapeutics, Inc. Stock Rating

Data Unavailable

Xilio Therapeutics, Inc. Stock Price History

Is XLO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
xiliotx.com

52-Week Data

52-Week High:
1.70
52-Week Low:
0.62

Prediction Charts

Market Cap:
35.1M
Price in USD:
0.67
Volume:
155.4K
Beta:
-0.05

Technical Analysis

SMA50:
0.75
SMA100:
0.74
SMA200:
0.75
52-Wk Change:
-28.68%

Stock Predictions

  • Is Xilio Therapeutics, Inc. stock public?
    Yes, Xilio Therapeutics, Inc. is a publicly traded company.
  • What is the Xilio Therapeutics, Inc. stock quote today?
    The Xilio Therapeutics, Inc. stock price is 0.67 USD today.
  • How to buy Xilio Therapeutics, Inc. stock online?
    You can buy Xilio Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 0.72 0.71 0.74 0.70
Dec-3 0.70 0.71 0.74 0.69
Dec-4 0.72 0.74 0.75 0.70
Dec-5 0.73 0.73 0.74 0.69
Dec-8 0.70 0.73 0.73 0.68
Dec-9 0.73 0.73 0.74 0.71
Dec-10 0.73 0.72 0.73 0.71
Dec-11 0.72 0.71 0.73 0.71
Dec-12 0.71 0.68 0.73 0.67
Dec-15 0.69 0.65 0.70 0.64
Dec-16 0.65 0.65 0.68 0.64
Dec-17 0.65 0.65 0.66 0.64
Dec-18 0.65 0.65 0.67 0.63
Dec-19 0.67 0.67 0.68 0.65

Xilio Therapeutics, Inc. Earnings

Data Unavailable

Xilio Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.01 per share, and a decrease next year of $0.30 per share.

* Xilio Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.